Brooks Laboratories Limited (BOM:533543)
India · Delayed Price · Currency is INR 70.00
-2.33 (-3.22%)
At close: Apr 16, 2026
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 2.12 billion as of April 16, 2026. Its market cap has decreased by -40.69% in one year.
Market Cap
2.12B
Enterprise Value
2.19B
Revenue
888.46M
Ranking
n/a
PE Ratio
9.83
Stock Price
70.00
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 2.12B, an increase of 1,917.82%. That is a compound annual growth rate of 22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 2.12B | -10.07% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sat Kartar Life | 3.07B |
| Trident Lifeline | 2.93B |
| Gennex Laboratories | 2.43B |
| Everest Organics | 2.33B |
| Ambalal Sarabhai Enterprises | 2.20B |
| BDH Industries | 2.15B |
| Sanjivani Paranteral | 2.05B |
| Oxygenta Pharmaceutical | 1.96B |